UCB SA Non-GAAP EPS of Euro9.99, revenue of Euro7.74B; introduces FY26 outlook
Source: SeekingAlpha
2026-02-26 01:51:02 ET
More on UCB SA
- UCB SA (UCBJY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- UCB SA (UCBJY) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- Seeking Alpha’s Quant Rating on UCB SA
- Historical earnings data for UCB SA
- Dividend scorecard for UCB SA
Read the full article on Seeking Alpha
For further details see:
UCB SA Non-GAAP EPS of €9.99, revenue of €7.74B; introduces FY26 outlook
UCB SA ADR
NASDAQ: UCBJY
UCBJY Trading
2.87% G/L:
$150.39 Last:
18,525 Volume:
$149.22 Open:
UCBJY Latest News
December 08, 2025 07:00:00 am
UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduced countable motor seizure frequency in CDKL5 deficiency disorder
December 04, 2025 08:12:00 am
UCB shares leading scientific research and advances at American Epilepsy Society Annual Meeting
